Skip to content
Drug Regulatory Authority of Pakistan

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو |  English
  • facebook-square
  • x
  • envelope

Menu

  • About Us
    • DRAP at a Glance
    • Organization
    • Executive Management
    • Legislation
    • Boards and Committees
    • Quality Management System
  • Therapeutic Goods
    • Drugs
    • Medical Devices
    • Alternative Medicine
    • Controlled Substances
    • Emergency Use Authorizations
    • Clinical Trials Oversight
    • Licensing and Inspections
    • Quality Controls Labs
    • Import & Export
    • Advertisement Approvals
  • Safety Info
    • Product Recalls
    • Safety Communication
    • Safety Reporting
  • News & Updates
    • Regulatory Updates
    • Press Releases
    • Careers
    • Tenders
    • Events
  • Publications
    • Essential Medicine Lists
    • Guidelines
    • Newsletters
    • Regulatory Procedures
    • Regulatory Fees
    • Application Forms
    • Public Consultation
    • Minutes of the Meetings
  • E-Services
  • Medicine Availability
    • Public Medicine Shortage Reporting
    • Hospital Medicine Shortage Reporting
    • Focal Person Nomination
  • Support
    • Facilitation Desk
    • Complaints
    • Contact Us
Home > Publications > Meeting Minutes > Medical Devices Board > Decisions of 65th Meeting of Medical Device Board (Deficiency letter for Medical Devices Applications)

Decisions of 65th Meeting of Medical Device Board (Deficiency letter for Medical Devices Applications)

Asad Ullah Medical Devices Board, Meeting Minutes April 8, 2024April 9, 2024Medical Devices

The Medical Device Board (MDB) of the Drug Regulatory Authority of Pakistan in 65th meeting has deferred the following applications of registration/enlistment of medical devices due to various deficiencies/shortcomings in the applications dossiers. These applicants are requested to furnish the requisite information/documentation as directed by the Medical Device Board. The detail is provided in the below attachment.

Defered-Letter-of-65th-Meeting-of-MDBDownload

Share this:

  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • ← Combating Substandard and Falsified Products : Public Alert Reporting
  • Stakeholder Nominations are invited to a Webinar on GMP for Blood Establishment →
  • Guidelines
    • Pharmaceuticals
    • Biologicals
    • Medical Devices
    • Alternative Medicines & Health Products
    • Pharmacy Services
    • Pharmacovigilance
    • Quality Assurance
  • Newsletters
  • Regulatory Procedures
  • Regulatory Fees
  • Application Forms
  • Public Consultations
    • Invitation for Comments
    • About Consultations
    • How to Submit Comments
  • Minutes of the Meetings
    • Registration Board
    • Central Licensing Board
    • Medical Devices Board
    • Enlistment Evaluation Committee
    • Clinical Studies Committee
    • Pharmacovigilance RAE Committee

Quick Navigation

     
  • Registered Drugs Index
  • Drug Pricing Index
  • List of Pharmaceutical Units

Archives

Drug Regulatory Authority of Pakistan

  • Islamabad | Karachi | Lahore | Peshawar | Quetta
  • Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
  • Website: www.dra.gov.pk
Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan
  • Contact Us
  • Report a Problem